bookmark

Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t) | Evidence-Based Mental Health

https://ebmh.bmj.com/content/22/1/e3?rss=1

Description

Commentary on: Deakin B, Suckling J, Barnes TRE, et al. The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial. Lancet Psychiatry 2018;5:885–94.. To read the full article, log in using your NHS OpenAthens details.

Preview

Users

Comments and Reviewsshow / hide

Please log in to take part in the discussion (add own reviews or comments).

BibSonomy